Your session is about to expire
← Back to Search
Sexual Assault Resistance Program for Preventing Victimization (IDEA3 Trial)
IDEA3 Trial Summary
This trial tests if a sexual assault resistance program can reduce victimization in college women, by comparing groups who attend 4 education sessions vs 1 workshop & surveys.
IDEA3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IDEA3 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for octogenarians to participate in this research?
"This trial is intended for individuals aged 17 to 24, with 4 separate trials designed for minors and 3 separate ones tailored towards older age groups."
Is recruitment currently underway for this trial?
"Affirmatively, this trial is actively enrolling participants according to findings on clinicaltrials.gov. Initially posted on October 2nd 2023 and last amended 17th of the same month, they are seeking a cohort of people for their research project."
How many participants are taking part in this experiment?
"Affirmative. Clinicaltrials.gov states that this clinical trial, first posted on October 2nd 2023, is presently recruiting for 1920 patients across 4 locations. The data was most recently updated on 10/17/2023."
In what geographic areas is this clinical trial being conducted?
"This trial has 4 active clinical sites, with the University of Nebraska - Lincoln in Lincoln, University of Guelph in Guelph and University of Windsor in Windsor being some prominent examples."
What type of individual is best suited to partaking in this experimentation?
"This research trial is currently enrolling 1920 young adults who have experienced sexual assault and meet the following criteria: pairing with another qualified student, 1st- or 2nd-year university students at one of 4 sites, female identification, ages 17 through 24, availability to attend a program group."
Share this study with friends
Copy Link
Messenger